Intracellular antibody‐mediated immunity and the role of TRIM21

Protection against bacterial and viral pathogens by antibodies has always been thought to end at the cell surface. Once inside the cell, a pathogen was understood to be safe from humoral immunity. However, it has now been found that antibodies can routinely enter cells attached to viral particles and mediate an intracellular immune response. Antibody‐coated virions are detected inside the cell by means of an intracellular antibody receptor, TRIM21, which directs their degradation by recruitment of the ubiquitin‐proteasome system. In this article we assess how this discovery alters our view of the way in which antibodies neutralise viral infection. We also consider the antiviral function of TRIM21 in the context of its other reported roles in immune signalling and autoimmunity. Finally, we discuss the conceptual implications of intracellular antibody immunity and how it alters our view of the discrete separation of extracellular and intracellular environments.

[1]  J. Yewdell,et al.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands , 2011, Cellular and Molecular Life Sciences.

[2]  Jeremy Luban,et al.  TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.

[3]  H. Erdjument-Bromage,et al.  Fas-associated Death Domain (FADD) and the E3 Ubiquitin-Protein Ligase TRIM21 Interact to Negatively Regulate Virus-induced Interferon Production* , 2010, The Journal of Biological Chemistry.

[4]  L. James,et al.  Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21) , 2010, Proceedings of the National Academy of Sciences.

[5]  R. Fuchs,et al.  Uncoating of human rhinoviruses , 2010, Reviews in medical virology.

[6]  T. Kamitani,et al.  Cytoplasmic relocation of Daxx induced by Ro52 and FLASH , 2010, Histochemistry and Cell Biology.

[7]  R. Higgs,et al.  Self Protection from Anti-Viral Responses – Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors , 2010, PloS one.

[8]  K. Ozato,et al.  Comment on “Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts” , 2009, The Journal of Immunology.

[9]  K. Wada,et al.  Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling. , 2009, Journal of biochemistry.

[10]  V. Kuchroo,et al.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathway , 2009, The Journal of experimental medicine.

[11]  K. Ozato,et al.  Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts1 , 2009, The Journal of Immunology.

[12]  S. Inoue,et al.  Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. , 2009, Cell host & microbe.

[13]  She Chen,et al.  TRIM21 Is Essential to Sustain IFN Regulatory Factor 3 Activation during Antiviral Response1 , 2009, The Journal of Immunology.

[14]  R. Higgs,et al.  The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-β Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF31 , 2008, The Journal of Immunology.

[15]  A. Ballabio,et al.  Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties , 2008, BMC Evolutionary Biology.

[16]  L. James,et al.  TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved , 2008, Proceedings of the National Academy of Sciences.

[17]  E. De Clercq,et al.  Recovery of Humoral Immunity Is Critical for Successful Antiviral Therapy in Disseminated Mouse Adenovirus Type 1 Infection , 2008, Antimicrobial Agents and Chemotherapy.

[18]  F. Bushman,et al.  The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22 , 2008, PLoS pathogens.

[19]  D. Burton,et al.  Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.

[20]  Hyun Kook Cho,et al.  Cutting Edge: Autoantigen Ro52 Is an Interferon Inducible E3 Ligase That Ubiquitinates IRF-8 and Enhances Cytokine Expression in Macrophages1 , 2007, The Journal of Immunology.

[21]  J. Trowsdale,et al.  Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function , 2007, Proceedings of the National Academy of Sciences.

[22]  D. Griffin,et al.  Synergistic Roles of Antibody and Interferon in Noncytolytic Clearance of Sindbis Virus from Different Regions of the Central Nervous System , 2007, Journal of Virology.

[23]  Y. Kawaoka,et al.  Protective efficacy of neutralizing antibodies against Ebola virus infection. , 2007, Vaccine.

[24]  Andrea Michael Meyer,et al.  Regulation of p27 Degradation and S-Phase Progression by Ro52 RING Finger Protein , 2006, Molecular and Cellular Biology.

[25]  C. Cunningham-Rundles,et al.  X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients , 2006, Medicine.

[26]  Carl S. Goodyear,et al.  Confounding B-cell defences: lessons from a staphylococcal superantigen , 2006, Nature Reviews Immunology.

[27]  K. Smith,et al.  Insights into post-infectious bronchiolitis obliterans in children , 2006, Thorax.

[28]  G. Diette,et al.  Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis , 2006, Thorax.

[29]  S. Nisole,et al.  TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.

[30]  K. Reimann,et al.  Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus , 2005, Nature Medicine.

[31]  H. Billett,et al.  Chronic parvovirus infection and G6PD deficiency masquerading as Diamond–Blackfan anemia , 2005, American journal of hematology.

[32]  E. Herlenius,et al.  Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block , 2005, The Journal of experimental medicine.

[33]  Corrie Brown,et al.  Fatal Disseminated Mouse Adenovirus Type 1 Infection in Mice Lacking B Cells or Bruton's Tyrosine Kinase , 2004, Journal of Virology.

[34]  A. Plebani,et al.  Search for poliovirus long-term excretors among patients affected by agammaglobulinemia. , 2004, Clinical immunology.

[35]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[36]  R. Jonsson,et al.  Subcellular Redistribution and Surface Exposure of the Ro52, Ro60 and La48 Autoantigens During Apoptosis in Human Ductal Epithelial Cells: a Possible Mechanism in the Pathogenesis of Sjögren's Syndrome , 2002, Scandinavian journal of immunology.

[37]  Q. Sattentau,et al.  Occupancy and mechanism in antibody-mediated neutralization of animal viruses. , 2002, The Journal of general virology.

[38]  V. Fadok,et al.  Apoptotic cell removal , 2001, Current Biology.

[39]  Alessandro Guffanti,et al.  The tripartite motif family identifies cell compartments , 2001, The EMBO journal.

[40]  P. Iannetti,et al.  Low-dosage immunoglobulins for an infant with hypogammaglobulinemia, maple syrup urine disease, and parvovirus B19-associated aplastic crisis. , 2000, Journal of pediatric hematology/oncology.

[41]  F. Rodríguez,et al.  The role of B lymphocytes in coxsackievirus B3 infection. , 1999, The American journal of pathology.

[42]  O. Ruuskanen,et al.  Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. , 1999, American journal of respiratory and critical care medicine.

[43]  J. Segovia,et al.  Severe Leukopenia and Dysregulated Erythropoiesis in SCID Mice Persistently Infected with the Parvovirus Minute Virus of Mice , 1999, Journal of Virology.

[44]  V. Fadok,et al.  Apoptosis: Getting rid of the bodies , 1998, Current Biology.

[45]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[46]  H. de Thé,et al.  Resistance to Virus Infection Conferred by the Interferon-Induced Promyelocytic Leukemia Protein , 1998, Journal of Virology.

[47]  M. Satoh,et al.  Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. , 1997, The Journal of rheumatology.

[48]  A. Levinson,et al.  B-Cell superantigens: Definition and potential impact on the immune response , 1995, Journal of Clinical Immunology.

[49]  J. Ahearn,et al.  Novel packages of viral and self-antigens are generated during apoptosis , 1995, The Journal of experimental medicine.

[50]  P. D'eufemia,et al.  Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy. , 1994, The Pediatric infectious disease journal.

[51]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[52]  Ari Helenius,et al.  Stepwise dismantling of adenovirus 2 during entry into cells , 1993, Cell.

[53]  A. Mosser,et al.  Postabsorption neutralization of poliovirus , 1993, Journal of virology.

[54]  T S Baker,et al.  Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody , 1993, Journal of virology.

[55]  E. Moxon,et al.  Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature review , 1992, Journal of Clinical Immunology.

[56]  W. Schleif,et al.  Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody , 1992, Nature.

[57]  D. Lyles,et al.  Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus , 1991, Journal of virology.

[58]  L. Pirofski,et al.  Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  E. Ben-Chetrit,et al.  Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome. , 1990, Arthritis and rheumatism.

[60]  F. K. Pedersen,et al.  Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia , 1989, European Journal of Pediatrics.

[61]  R. Levinsky,et al.  Dual meningoencephalitis with echovirus type 11 and adenovirus in combined (common variable) immunodeficiency. , 1988, The Pediatric infectious disease journal.

[62]  K. Sullivan,et al.  A 52-kD protein is a novel component of the SS-A/Ro antigenic particle , 1988, The Journal of experimental medicine.

[63]  S. Katz,et al.  Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. , 1987, Reviews of infectious diseases.

[64]  L. Kjellén A hypothesis accounting for the effect of the host cell on neutralization-resistant virus. , 1985, The Journal of general virology.

[65]  H. Moutsopoulos,et al.  Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. , 1985, Annals of the rheumatic diseases.

[66]  E. Wimmer,et al.  Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization , 1983, Journal of virology.

[67]  A. Villarreal,et al.  Antibody and interferon act synergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection , 1983, Infection and immunity.

[68]  R. Rueckert,et al.  Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. , 1983, Virology.

[69]  E. Wimmer,et al.  Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies , 1983, Journal of virology.

[70]  S. Dikman,et al.  Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient. , 1981, The American journal of medicine.

[71]  D. O. White,et al.  Antigenic determinants of influenza virus hemagglutinin. VIII. Topography of the antigenic regions of influenza virus hemagglutinin determined by competitive radioimmunoassay with monoclonal antibodies. , 1981, Virology.

[72]  F. Rosen,et al.  Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. , 1977, The New England journal of medicine.

[73]  R. Keller Studies on the mechanism of the enzymatic reactivation of antibody-neutralized poliovirus. , 1968, Journal of immunology.

[74]  R. Dulbecco,et al.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. , 1956, Virology.

[75]  K. Wada,et al.  Ro52-mediated Monoubiquitination of IKK b Down-regulates NF- i B Signalling , 2009 .

[76]  H. Zeichhardt,et al.  Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion , 2005, Archives of Virology.

[77]  P. Plotz,et al.  The autoantibody repertoire: searching for order , 2003, Nature Reviews Immunology.

[78]  J. Castro‐Rodriguez,et al.  Recurrent pneumonia as warning manifestation for suspecting primary immunodeficiencies in children. , 2001, Journal of investigational allergology & clinical immunology.

[79]  M. Mattéi,et al.  The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms. , 1993, American journal of human genetics.

[80]  B. McManus,et al.  Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[81]  S. Katz,et al.  CHRONIC ENTEROVIRAL MENINGOENCEPHALITIS IN AGAMMAGLOBULINEMIC PATIENTS , 1988 .

[82]  Claes WOHLFARTt Neutralization of Adenoviruses: Kinetics, Stoichiometry, and Mechanisms , 2022 .